RG
PLRX icon

Redmile Group’s Pliant Therapeutics PLRX Stock Holding History

Redmile Group’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$973K Sell
772,126
-844,102
-52% -$1.07M 0.06% 35
2025
Q4 		$1.97M Buy
1,616,228
+24,533
+2% +$36.9K 0.15% 33
2025
Q3 		$2.36M Sell
1,591,695
-40,882
-3% -$62.4K 0.23% 36
2025
Q2 		$1.89M Sell
1,632,577
-420,982
-21% -$595K 0.2% 43
2025
Q1 		$2.77M Sell
2,053,559
-841,919
-29% -$5.11M 0.26% 45
2024
Q4 		$38.1M Sell
2,895,478
-302,013
-9% -$4.12M 2.66% 11
2024
Q3 		$35.8M Sell
3,197,491
-12,100
-0.4% -$151K 2.11% 23
2024
Q2 		$34.5M Buy
3,209,591
+112,371
+4% +$1.45M 2.09% 20
2024
Q1 		$46.1M Buy
3,097,220
+400,572
+15% +$6.61M 1.69% 22
2023
Q4 		$48.8M Buy
2,696,648
+18,549
+0.7% +$282K 1.75% 16
2023
Q3 		$46.4M Hold
2,678,099
– – 2.21% 9
2023
Q2 		$48.5M Sell
2,678,099
-247,549
-8% -$5.86M 1.86% 13
2023
Q1 		$77.8M Sell
2,925,648
-952,951
-25% -$27.1M 3.38% 6
2022
Q4 		$75M Sell
3,878,599
-629,605
-14% -$13.2M 3.07% 9
2022
Q3 		$94.2M Buy
4,508,204
+1,439,203
+47% +$27.5M 3.65% 5
2022
Q2 		$24.6M Sell
3,069,001
-11,800
-0.4% -$75.6K 0.94% 31
2022
Q1 		$21.6M Sell
3,080,801
-2,700
-0.1% -$27.6K 0.67% 40
2021
Q4 		$41.6M Hold
3,083,501
– – 0.95% 32
2021
Q3 		$52M Sell
3,083,501
-72,900
-2% -$1.55M 0.91% 35
2021
Q2 		$91.9M Sell
3,156,401
-50,792
-2% -$1.58M 1.36% 25
2021
Q1 		$126M Sell
3,207,193
-181,183
-5% -$5.88M 1.78% 16
2020
Q4 		$77M Sell
3,388,376
-3,381
-0.1% -$84.8K 0.93% 37
2020
Q3 		$76.8M Sell
3,391,757
-18,900
-0.6% -$472K 1.41% 23
2020
Q2 		$111M Buy
+3,410,657
New +$90.5M 2.04% 13

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Redmile Group's PLRX Position: Q1 2026 in Review

Redmile Group reduced its Pliant Therapeutics (PLRX) stake by 52% in Q1 2026, selling an estimated $1.07M and leaving 772,126 shares worth $973K. The position accounts for 0.06% of the portfolio, ranked #35.

Redmile Group first reported a position in PLRX in Q2 2020 and has held it in 24 quarters since. The position peaked at $126M in Q1 2021. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

  • Redmile Group held 772,126 shares of Pliant Therapeutics worth $973K as of Q1 2026.
  • Redmile Group sold 844,102 Pliant Therapeutics shares in Q1 2026, an estimated $1.07M.
  • Pliant Therapeutics made up 0.06% of Redmile Group's portfolio in Q1 2026, its #35 holding.
  • Redmile Group first reported a position in Pliant Therapeutics in Q2 2020 and has held it in 24 quarters since.
  • Redmile Group's Pliant Therapeutics position peaked at $126M in Q1 2021.
  • 91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on Redmile Group's 13F filing for Q1 2026, filed 15 May 2026.